Genomenon Webinars

Learn from the experts in genomics

LATEST WEBINAR
MASTERMIND MASTERCLASS:
SENSITIVITY & SPECIFICITY IN GENOMIC SEARCH

Thursday, August 27, 2020 | 11 a.m. EDT
In this Masterclass, Genomenon co-founders Dr. Mark Kiel and Steve Schwartz discuss how Mastermind optimizes specificity and then sensitivity when searching for insight into patient variants and resolving VUSs for optimal diagnostic yield.

Learn more

<h5>LATEST WEBINAR<br><b>MASTERMIND MASTERCLASS:<br>SENSITIVITY & SPECIFICITY IN GENOMIC SEARCH</b>
MASTERMIND MASTERCLASS: GENOMIC ASSOCIATIONS

CLINICAL | PHARMA

In this Masterclass, co-founders, CSO Dr. Mark Kiel and CTO Steve Schwartz describe how to harness the power of comprehensive evidence-based data for use in clinical workflows to answer specific questions about genes and variants, as well as in drug discovery to answer more open-ended questions and uncover associations that were not previously known to the searcher.

Watch the recording

INCREASING CASE THROUGHPUT WITH IMMEDIATE INSIGHT INTO CLINICALLY RELEVANT EVIDENCE

CLINICAL

In this webinar, Helen Savage at Congenica and Dr. Mark Kiel look at a key part of the clinical interpretation workflow and reveal how a combination of new tools is helping to break through the interpretation bottleneck, enabling you to instantly identify and analyze genetic evidence found across the complete corpus of scientific articles, faster and with greater confidence than ever before.

Watch the recording

BIG DATA FOR RARE DISEASE: USING GENOMIC LANDSCAPES TO ACCELERATE DRUG DEVELOPMENT

PHARMA

In this webinar for Pharma, Dr. Mark Kiel uses real-world examples to demonstrate how Mastermind Genomic Landscapes have empowered pharmaceutical researchers and translational teams to understand rare diseases at the molecular level.

Watch the recording

MASTERMIND MASTERCLASS: ACMG/AMP CLASSIFICATION

CLINICAL

Co-founders Dr. Mark Kiel and Steve Schwartz led a live discussion and demonstration of the ACMG/AMP filtering process in the Mastermind Genomic Search Engine.

Watch the recording

GAINING INSIGHT INTO KNOWN AND NOVEL THERAPIES TO DRIVE DRUG DISCOVERY

PHARMA

In this webinar for Pharma, Dr. Mark Kiel demonstrated how therapeutic associations between diseases, genes, variants, and phenotypes are a powerful tool in drug development.

Watch the recording

COMPREHENSIVE GENOMIC ASSOCIATION DATA FOR GENETIC VARIANT INTERPRETATION

CLINICAL | PHARMA

At this LabRoots Virtual Event, Dr. Mark Kiel presented how Genomenon’s approach to Big Data and Artificial Intelligence allow the variant scientist to understand genomic associations across the entirety of the empirical evidence from the medical literature.

Visit LabRoots to watch on demand

MASTERMIND MASTERCLASS: THERAPIES

CLINICAL

The Mastermind Genomic Search Engine now includes the ability to search the genomic literature by therapy. Co-founders Dr. Mark Kiel and Steve Schwartz led a virtual guided tour of the new Therapies search feature and live Q&A.

Watch the recording

GENOMIC LANDSCAPES: LEVERAGING GENETIC EVIDENCE THROUGHOUT THE PHARMA PIPELINE

PHARMA

At the 2020 LabRoots Genetics Virtual Week, Dr. Mark Kiel presented how Genomenon provides invaluable insight into the genomic drivers of disease and an understanding of the molecular drivers that influence all aspects of the drug development pipeline.

Visit LabRoots to watch on demand

MASTERMIND MASTERCLASS: HUMAN PHENOTYPE ONTOLOGY

CLINICAL

With the release of version 2.0, the Mastermind Genomic Search Engine now includes the ability to search the genomic literature by phenotype. Co-founders Dr. Mark Kiel and Steve Schwartz led a virtual guided tour of the new HPO search feature and live Q&A.

Watch the recording

USING GENOMICS TO ACCELERATE DRUG DEVELOPMENT FOR NEURODEGENERATIVE DISEASES

PHARMA

In this webinar, Dr. Mark Kiel used real-world examples to demonstrate how a Comprehensive Genomic Landscape for a disease, pathway or gene set has empowered Pharmaceutical researchers and translational teams to understand genetic and rare diseases at the molecular level.

Watch the recording

HOW TO LEVERAGE THE GENOMIC LANDSCAPE TO ACCELERATE PRECISION MEDICINE

PHARMA

Realizing the promise of Precision Medicine requires both a deep understanding of the genomic evidence and an understanding of the molecular drivers that influence the drug development pipeline. In this webinar, Founder & CSO Dr. Mark Kiel discussed the vital role that genomics plays in the pharmaceutical development process.

Watch the recording

RADY CHILDREN’S INSTITUTE FOR GENOMIC MEDICINE – ASHG 2019 COLAB

CLINICAL

At the 2019 American Society of Human Genetics (ASHG) Annual Meeting, Dr. Kasia Ellsworth of Rady Children’s Institute for Genomic Medicine presented at the Genomenon CoLab Session: “Automated Literature Curation and Variant Interpretation Pipelines with Mastermind following rWGS within the Pediatric ICU – the RCIGM Experience”.

Watch presentation

UNIVERSITY OF PITTSBURGH MEDICAL CENTER – ASHG 2019 COLAB

CLINICAL

At the 2019 American Society of Human Genetics (ASHG) Annual Meeting, Dr. Daniel Bellissimo of the University of Pittsburgh Medical Center Clinical Genomics Laboratory presented at the Genomenon CoLab Session: “Mastermind: Advanced Literature Searching to Aid Variant Classification”.

Watch presentation

REAL-WORLD EXAMPLES OF EFFICIENCY IN GAINS IN THE ANALYSIS & INTERPRETATION OF GENOMIC DATA

CLINICAL

In this webinar, Dr. Mark Kiel welcomed our guest Dr. Eva Serra, who demonstrated Congenica, a way to overcome challenges in the analysis, interpretation and reporting of complex genomic data with an all-in-one solution that optimizes process efficiency from raw data to report.

Watch the recording

3 SIMPLE STEPS TO DIAGNOSE RARE DISEASES IN MINUTES

CLINICAL

In this webinar, Drs. Cyrielle Kint from Diploid and Mark Kiel from Genomenon introduced us to Moon, and demonstrated how the integration with Mastermind allows you to easily assess related variants that have been reported in literature.

View the Q&A

DRUG DISCOVERY IN THE AGE OF GENOMICS

CLINICAL | PHARMA

Currently, only 10% of drug therapies actually reach patients because the genetic mechanisms of disease and their consequences for drug action are not well understood. In this webinar, genomics experts Drs. Mark Kiel and Alex Joyner describe the deep and invaluable connection between therapeutics development and genomics, and how to obtain and use NGS data to improve outcomes.

Watch the recording

CHARACTERIZING TARGETED CANCER THERAPIES VIA A COMPREHENSIVE GENE FUSION DATABASE

CLINICAL | PHARMA

Genomenon has developed the most comprehensive database of gene fusion pairs found within the scientific literature. This complete literature catalogue for the 507 genes from the Illumina TruSight RNA Fusion Panel contains all known fusion pairs, with reference citations for every scholarly paper citing the chimeric genes.

Watch the recording

MAPPING THE GENOMIC LANDSCAPE TO ACCELERATE PRECISION DRUG DEVELOPMENT

CLINICAL | PHARMA

Rhythm Pharmaceuticals and Genomenon discuss their efforts to assemble a database of mutations associated with rare genetic disorders of obesity, and how this was optimized to facilitate a deep understanding of the variant landscape of melanocortin-4 receptor (MC4R)-pathway genes.

Watch the recording

MINING GENOMIC LITERATURE FOR VARIANT INTERPRETATION AND GENE PANEL DESIGN

CLINICAL

Watch an expert panel discuss how they used the new Mastermind Genomic Search Engine to mine the full text of the genomic literature for two key applications: variant interpretation and the development of evidence-based diagnostic gene panels.

Watch the recording

AUTOMATED BIOMARKER SELECTION FOR EVIDENCE-BASED GENE PANEL DESIGN

CLINICAL

Dr. Mark Kiel presents the biomarker selection process and results for the first comprehensive evidence-based Pan-Hematopoietic Malignancy Gene Panel using the Mastermind Genomic Search Engine.

Watch the recording

ACCELERATING PATIENT DIAGNOSIS WITH AUTOMATED LITERATURE CURATION FOR INHERITED DISEASE

CLINICAL | PHARMA

Dr. Mark Kiel and Veritas Genetics VP of Clinical Affairs Birgit Funke discuss an approach for automating variant classification based on the American College of Medical Genetics and Genomics guidelines.

Watch the recording

IS GENOMIC MEDICINE READY FOR AI?

CLINICAL | PHARMA

Genome sequencing promises to improve diagnostic accuracy and patient outcomes in both oncology and genetics, but the volume and complexity of the data requires a significant manual process to ensure high-quality interpretation. Dr. Mark Kiel offers insight on Artificial Intelligence and its impact on Genomic Medicine.

Watch the recording

Have questions about Genomenon? Let’s talk!